Compounds > bay-60-6583

bay-60-6583 and Squamous-Cell-Carcinoma-of-Head-and-Neck

bay-60-6583 has been researched along with Squamous-Cell-Carcinoma-of-Head-and-Neck* in 1 studies

Other Studies

1 other study(ies) available for bay-60-6583 and Squamous-Cell-Carcinoma-of-Head-and-Neck

ArticleYear
Co-inhibition of adenosine 2b receptor and programmed death-ligand 1 promotes the recruitment and cytotoxicity of natural killer cells in oral squamous cell carcinoma.
    PeerJ, 2023, Volume: 11

    Topics: Adenosine A2 Receptor Antagonists; B7-H1 Antigen; Drug Inverse Agonism; Humans; Killer Cells, Natural; Mouth Neoplasms; NF-kappa B; Receptors, Adenosine A2; Squamous Cell Carcinoma of Head and Neck; Tumor Microenvironment

2023